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Abstract Objectives: To review the options available to patients with faecal
incontinence with failed conservative treatment and/or failed anal sphincter repair
and assessing the current indications and results of these options.
Methods: A literature search of MEDLINE, EMBASE and Cochrane databases was
performed using the relevant search terms.
Results: Continent options for patients with severe or end stage faecal in-
continence include the creation of a form of an anal neosphincter and more
recently sacral nerve stimulation. Over half the patients, who are candidates, may
benefit from these procedures, although long term results of sacral nerve
stimulation are unknown. Dynamic graciloplasty improves the continence in 44e
79% of the patients. The complications include frequent reoperations, high
incidence of infection and obstructive defaecation. The success rates of artificial
bowel sphincter vary between 24% and 79%. Once functional, the artificial bowel
sphincter seems to improve the continence in the majority of the patients. Device
removal due to infection, obstructive defaecation and pain is a frequent problem.
Sacral nerve stimulation is claimed to result in improvement in continence in 35e
100% of patients. The main risks in this procedure are infection, electrode
displacement and pain.
Conclusions: All these procedures have high complication rates and have moderate
success rates only. A major proportion of patients will need reoperations and hence
high motivation is necessary for patients who undergo these procedures. A uniform
standard for measurement of success is also necessary so that these procedures can
be compared with each other.
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Faecal incontinence affects an estimated 2% of the
general population.1 This tends to be under-
reported by patients, largely as a result of embar-
rassment and unwillingness to discuss the problem
with their family or their doctors.2 The prevalence
of faecal incontinence is even higher in older
population.3 It is usually quite distressing for
patients and does severely affect their social life.
Conservative medical management is usually
tried first in most patients. Options include the
use of anti-diarrhoeal medications, bulk laxatives
as well as biofeedback. Conservative treatment
succeeds in many, but not in all patients. Patients
with anal sphincter defects and significant incon-
tinence, who do not fare well on conservative
measures, are candidates for overlapping sphinc-
ter repair. This succeeds in many patients. Occa-
sionally a repeat sphincter repair can be
performed, again with success in many patients.
There are, however, patients who would fail this
or may not be candidate for such repairs such as
patients with extensive sphincter destruction or
those with neurogenic incontinence. In addition,
patients with anorectal agenesis and absent anal
sphincter or those who loose their sphincters
following abdominoperineal resection obviously
cannot be helped by sphincter repairs. These
patients have been traditionally offered perma-
nent stomas.
Stomas, however, may have a profound negative
impact on the lifestyle of patients as well as their
quality of life.4,5 This has always led to patients
and physicians exploring alternatives to perma-
nent stoma. This quest has resulted in various
‘‘neosphincters’’ in the last two decades and more
recently interest in neuromodulation of anal
sphincters. The aim of this review is to look at
the current results of these procedures.
Methods
A literature search of MEDLINE (1966e2004), EM-
BASE (1974e2004), and Cochrane databases (Issue
3, 2004) was performed to identify the articles to be
included. The search terms that we used were
‘‘artificial’’ AND ‘‘anus OR anal OR bowel’’ AND
‘‘sphincter*’’ (text), ‘‘neosphincter*’’ (text), ‘‘gra-
ciloplast*’’ (text), ‘‘(fecal OR faecal) AND (conti-
nent* OR incontinent*) (text), ‘‘fecal incontinence’’
(MeSH), ‘‘anus’’ (MeSH), ‘‘Electric stimulation ther-
apy’’ (MeSH), ‘‘Reconstructive Surgical Procedures’’
(MeSH). Further search through the reference
section of relevant articles was performed toidentify any missed studies. All published studies
which reported on at least five patients were
included for this review. Reports of surgeries
performed mainly after total anorectal recon-
struction were excluded from the review. There
were no language or study design restrictions.
Neosphincter procedures
Alternatives to permanent stomas have been de-
veloped over many years. Initially, various skeletal
muscles were wrapped around the anus as a re-
placement sphincter (a neosphincter). The earliest
reported attempt utilized the gluteus maximus
muscle at the turn of the last century.6 The gracilis
muscle, however, was much more popular in this
regard, because of the nature of its neurovascular
supply, its superficial location and also because it
does not have any major function. Few authors
reported the use of other skeletal muscles like
adductor longus7 or free autogenous muscle trans-
plants.8 Smooth muscle wraps9 has also been de-
scribed. The introduction of electro-stimulation
rekindled the interest in the gracilis muscle, which
remains the most popular form of a muscle neo-
sphincter.
Parallel to the development of the electro-
stimulated muscle neosphincter, a totally artificial
bowel sphincter was developed10,11 which main-
tains anal continence by an occluding cuff wrap-
ped around the anal canal.
Dynamic (electrostimulated)
graciloplasty
Graciloplasty had been described over 50 years ago
by Pickrell et al.12 The popularity of unstimulated
graciloplasty has waxed and waned over the years.
Despite early enthusiasm, the results has been
generally inconsistent,13 but mostly poor. The
fundamental problem with these procedures has
been the reliance on voluntary contraction of
these e fatigue prone (Type 2 muscle fibres) e
muscles for extended periods of time to attain
continence. To tackle this serious limitation of
these procedures, a revolutionary concept was
developed in the late 1980s, namely chronic
muscle electro-stimulation. The idea behind this
was to convert the easily fatiguable fast twitch
Type 2 muscle fibres (ordinary muscles) into
fatigue resistant slow contracting Type 1 muscle
fibres (suitable for function as a sphincter, capable
of sustained contraction).14,15
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performed in two different ways e using intramus-
cular electrodes16 and direct stimulation of gracilis
neurovascular bundle.17,18 The latter method
needs lower voltage and is probably more physio-
logical, but intramuscular electrodes may be more
secure with lesser chance of displacement and
appears to be the most widely used method.19
Many surgeons perform a graciloplasty first and
then implant the stimulator in the second stage.20
Rongen and associates21 have found it safe and
effective to implant the stimulator simultaneously
with the graciloplasty as a single stage procedure.
Matzel and associates22 found no difference in the
complication rates between a single-stage and
a two-stage procedure. Colostomy was performed
routinely by some authors while others did not
perform a covering colostomy. A diverting colos-
tomy does not seem to decrease the wound
complication rate.23
Many reports have been published on dynamic
graciloplasty (Table 1a e results, b e complica-
tions) on over 400 patients. Most studies reported
small number of patients with an overall improve-
ment in continence in over half the patients with
a follow-up ranging from 7 months to more than 4
years.23e28 Overall, dynamic graciloplasty im-
proves continence in over half the patients. The
results of larger series approach 70% major im-
provement in continence (patients either attaining
full continence or are continent to solids and
liquids). Differences in success rates between
series are wide (44e79%) and may be related to
the steep learning curve associated with these
procedures,23,29 but also depends on the follow-up
period and definitions used by different authors for
measuring success and whether or not the re-
ported success rate was based on the number of
patients who finally had a functional neosphincter
or the number of patients entered into the study.
Dynamic graciloplasty has also been used for
total anorectal reconstruction following abdomi-
noperineal resection of the rectum. The success
rates of dynamic graciloplasty following APER
again vary between 40% and 80%.30e36 However,
results are worse than for dynamic graciloplasty
performed for incontinence. Very few patients
achieve full continence.31 Most of these studies
reported no local recurrence confirming that this is
a oncologically safe procedure.30,32e36 Although,
Cavina and associates35 confirmed the safety and
efficacy of the procedure performed in one stage,
many authors perform the procedure in 2 or 3
stages e APER followed by dynamic graciloplasty
and colostomy closure. All the studies report high
rates of complications which include colonicnecrosis, colonic fistulas and some authors have
given up the procedure in spite of a claimed
success rate of 71% because of the high incidence
of complications.37
The main reservations about dynamic gracilo-
plasty have been the high rates of infection,25,38,39
high rates of reoperations,23,24,40 complications
related to the implanted stimulator or leads and
obstructive defaecation.24,39,41 Furthermore, the
long term results of chronic electro-stimulation of
muscles are unknown. Experimental animal model
studies suggest that long term stimulation de-
creases the muscle fibre diameter and increases
the endomysial tissue42 and causes muscle de-
generation by affecting the collateral blood supply
to the muscles.43 Chronic exposure to radiofre-
quency waves may also induce some haematolog-
ical changes44,45 and brain activity.44
Another important consideration is the high
costs involved,46 especially in the developing
world. However, other studies report considerable
savings in patient costs following dynamic gracilo-
plasty as compared to stomas,47 even when the
indirect costs of failed procedures are included.
Furthermore, it is fair to say that it is not possible
to quantify the cost of the quality of life of the
patient.
Gluteoplasty
The use of gluteus maximus as an anal neosphinc-
ter started at the turn of the last century6 and has
been tried on and off by many surgeons over the
whole of last century. The gluteus maximus lends
itself in that role because it is an accessory muscle
of continence, but it is somewhat a more difficult
muscle to use than the gracilis and the access to its
neurovascular bundle is less familiar. Because of
these reasons, it never gained the same popularity
as the gracilis despite reports attesting to its
superiority compared to reports of unstimulated
graciloplasty.48 On the other hand, Christiansen
and associates49 found that the results of unstimu-
lated gluteoplasty were similar to that of unstimu-
lated graciloplasty.
With the experience in chronic stimulation of
muscle for graciloplasty, the interest in gluteo-
plasty has been renewed and dynamic gluteoplasty
has been attempted. Very few reports are avail-
able for dynamic gluteoplasty (Table 2a e results,
b e complications). However, due to the variations
in the nerve and blood supply, it is less reliable
than dynamic graciloplasty. Also, the functional
loss may be greater with gluteoplasty. The other
main problem with dynamic gluteoplasty is that
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(a) Results
Study
(Author, Year, Ref)
Number
of patients
Follow-up
(months)
Continent or major
improvement
in continence (%)a
Baeten et al., 199599 (also included in Rongen et al., 200327) 52 25 38 (73%)
Geerdes et al., 199638 67 32 52 (78%)
Wexner et al., 199641 17 Not reported 9 (53%)
Altomare et al., 199729 9 6 (min) in
5 patients
4 (44%)
Christiansen et al., 199824 13 7e27 6 (46%)
Sielezneff et al., 199939 16 20 10 (63%) fully continent
Mander et al., 1999100 64 16 29 (45%)
Madoff et al., 199923 128 24 85 (66%)
Baeten et al., 2000101 123 23 63 (51%)
Bresler et al., 200225 24 21 19 (79%) improved
significantly,
including 7 (29%) fully
continent
Wexner et al., 200226,b 129 24 83 (76%) 56e100%c
Rongen et al., 200327 200 24 (min) 145 (73%)
Penninckx, 200428 60 53 43 (72%) continent
to solid stools
(b) Complications
Study
(Author, Year, Ref)
Number of
patients
Obstructive
defaecation (%)
Infection (%) Explantation
(%)
Reoperations (%),
Pain (%)
Baeten et al., 199599 52 7 (13%) 4(8%)
Geerdes et al., 199638 67 13 (19%) (one
unresolved)
11 (16%)
Wexner et al., 199641 17 5 (29%) (1
requiring stoma)
5 (29%) 1 (6%) Replacement 4
(24%)
Altomare et al., 199729 9 3 (33%) Perianal abscess
1 (11%)
Tendon
detachment
2 (22%)
Christiansen et al., 199824 13 3 (23%) 8 (62%) Reoperations 8
(62%)
Sielezneff et al., 199939 16 5 (31%) 7 (44%) 1 (8%) 8 (50%) revisional
surgery
Mander et al., 1999100,b 64 16 (25%) 9 (14%)
severe
28 (44%)
Madoff et al., 199923,b 128 Anal strictures
requiring surgery
5 (4%)
14 (11%) requiring
surgery
Reoperations 46
(36%)
Pain 28 (22%)
Baeten et al., 2000101,b 123 28 (23%) 49 (40%) including
18 (15%) major
Tendon
detachment
6 (5%)
Pain 34 (28%)
Matzel et al., 200122,b 121 34 (28%)including
8 (7%) requiring
reoperation
52 (43%) including
19 (16%) major
and 29 (24%)
requiring
reoperation
109 (90%) some
patients requiring
multiple
reoperations)
Bresler et al., 200225 24 2 (8%) (severe) 6 (25%) 1(4%) Pain 4 (17%),
Tendon
detachment 4
(17%)
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(b) Complications
Study
(Author, Year, Ref)
Number of
patients
Obstructive
defaecation (%)
Infection (%) Explantation
(%)
Reoperations (%),
Pain (%)
Rongen et al., 200327 200 32 (16%) 24 (12%) Stimulator displacement
10 (5%)
Pain 30 (15%)
Penninckx, 200428 60 12 (20%) Device problems
10 (17%)
a Variable definitions of success were used by different authors. Most considered successful (or good) result to encompass full
continence (solids, liquid and gas) as well as those with continence to solids and liquids.
b All report about the same multicentric trial.
c Data for 109 patients depending of duration of symptoms.the voltages required are higher resulting in shorter
battery life.19
Artificial bowel sphincter
Another approach to constructing a neosphincter is
to replace the anal sphincter with a totally syn-
thetic device, designed to mimic the natural pro-
cess of bowel control and evacuation. This
basically consists of a cuff that is placed around
the anal canal, which is connected to a pressure
regulating balloon and a control pump placed in
the scrotum or labium majus, by which the patient
can deflate the cuff. Urinary incontinence has
been treated by a similar artificial sphincter for
more than 30 years.50 Extensive experience in over
1500 patients has shown this to be an effective
treatment in up to 75% of these patients. A
modified artificial urinary sphincter (modifiedAMS 800) was first used to treat faecal inconti-
nence by Christiansen and Lorentzen in 1987.10
Over the past years, repeated modifications have
been introduced to decrease the incidence of
mechanical failure and improve their function by
tailoring the devices to fit individual anal anatomy.
This resulted in the artificial bowel sphincter (ABS)
which was introduced in 1996 and is available in 14
different cuff sizes and three different widths.
More recently, a newer version (Acticon Neo-
sphincter) has appeared which has a longer cuff
and a larger (40 cc) pressure regulating balloon
and a septum port added to the control pump.
Other experimental designs, using memory shape
alloys, have also been proposed as alternatives.51
Many reports have been published since 1987
(Table 3a e results, b e complications) on over 400
patients. Most studies reported small numbers of
patients with an overall success rate varying
between 24% and 79% with a follow-up rangingTable 2 Dynamic gluteoplasty e (a) results (b) complications
(a) Results
Study
(Author, Year, Ref)
Number of
patients
Follow-up
(months)
Continent or major improvement in
continence (%)a
Guelinckx et al., 1996102 4 Mean basal pressure e 49 mmHg
Mean squeeze pressure e 125 mmHg
Madoff et al., 199923 11 5 (45%) showed more than 70%
improvement in continence
(b) Complications
Study
(Author, Year, Ref)
Number of
patients
Obstructive
defaecation (%)
Infection
(%)
Explantation
(%)
Reoperations (%),
Pain (%)
Madoff et al., 199923 11 1 (9%) Anal stricture 3 (27%) 2 (18%) Minor
Pain 4 (36%)
a Variable definitions of success were used by different authors. Most considered successful (or good) result to encompass full
continence (solids, liquid and gas) as well as those with continence to solids and liquids.
198 K.S. Gurusamy et al.Table 3 (a) Artificial anal sphincter e results (b) Artificial bowel sphincter e complications
(a) Artificial anal sphincter e results
Study
(Author, Year, Ref)
Number of
patients
Follow-up
(months)
Continent or major improvement
in continence (%)a
Wong et al., 1996103 12 58 6 (50%)
Vaizey et al., 199811 6 9 5 (83%)
Long term follow-up in Malouf et al., 200055
Christiansen et al., 199952 17 60 (min) 4 (24%)
8 (47%) functioning implants
Malouf et al., 200055 18 12 Early reports in Christiansen et al., 1992104
claimed a success rate of 80%
6 (33%)
Lehur et al., 200053 24 25 19 (79%) including 6 (25%) fully continent
20 (83%) functioning implants
Savoye et al., 200063 12 16 8 (67%)
O’Brien and Skinner, 200056 9 NR 7 (78%)
Altomare et al., 200164 28 19 21 (75%)
Wong et al., 200254 112 12 (min) 51 (46%)
Devesa et al., 200265 53 27 29 (55%) fully continent
51 (96%) continent to solids
Ortiz et al., 2002105 22 28 9 (41%)
Lehur et al., 200257 16 25 11 (69%)
12 (75%) functioning implants
Parker et al., 200358,b 10 91 6 (50%) functioning implants
Parker et al., 200358,b 35 39 3 (9%) fully continent
17 (49%) functioning implants
Michot et al., 200359 37 34 15 (60%)
DaSilva et al., 200466 11 12 Significant increase in the mean
continence scores and squeeze pressure
Casal et al., 200460 10 29 4 (40%)
Altomare et al., 200461 28 50 8 (29%)
17 (61%) functioning implants
(b) Artificial bowel sphincter e complications
Study
(Author, Year, Ref)
Number of
patients
Obstructive
defaecation
(%)
Infection (%) Explantation
(%)
Reoperation (%),
Pain (%),
Erosion (%)
Wong et al., 1996103 12 3 (25%) Reoperation 8 (67%),
Pain needing
relocation 1 (8%)
Vaizey et al., 199811 6 6 (100%) 2 (33%) Erosion 1 (17%)
Christiansen et al., 199952 17 1 (6%) 7(41%) Reoperation 5/8
(62.5%)
Malouf et al., 200555 18 1 (6%) requiring
explantation
7(39%)
MRSA in 6
12 (67%) Cuff erosion 2 (11%)
Lehur et al., 200053 24 9 (38%)
(2 severe)
7 (29%)
Savoye et al., 200063 12 6 (50%)
O’Brien and Skinner, 200056 9 3 (33%) requiring
removal
Altomare et al., 200164 28 12 (43%) 3 (11%) requiring
removal
5 (17%)
7 (25%)
persistent
Wong et al., 200254 112 30 (27%) 38 (34%) 41 (37%) Reoperation 73 (65%),
Pain 37 (33%)
28 (25%) requiring
reoperation
Erosion 27 (24%)
Devesa et al., 200265 53 11 (21%) 10 (19%) 10 (19%) Erosion 9 (17%)
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(b) Artificial bowel sphincter e complications
Study
(Author, Year, Ref)
Number of
patients
Obstructive
defaecation
(%)
Infection
(%)
Explantation
(%)
Reoperation (%),
Pain (%),
Erosion (%)
Ortiz et al., 2002105 22 2 (9%) requiring
explantation
8 (36%)
Lehur et al., 200257 16 5 (31%) 5 (31%)
Parker et al., 200358,b 10 3 (25%)c 4 (33%) Reoperation 8 (67%)
Parker et al., 200358,b 35 4 (11%) requiring
surgery
12 (34%) 14 (40%) Reoperation
21 (60%)
Pain 2 (6%)
Michot et al., 200359 37 7 (19%) 3 (8%) 11 (30%) Erosion 6 (16%)
DaSilva et al., 200466 11 3 (27%)
(faecal impaction)
1 (9%)
Casal et al., 200460 10 1 (10%) 3 (30%) e 1
permanent
Pain 1 (10%)
Altomare et al., 200461 28 7 (25%) 1 (4%) 11 (39%) Pain 4 (14%)
Follow-up of Altomare et al., 200164
a Variable definitions of success were used by different authors. Most considered successful (or good) result to encompass full
continence (solids, liquid and gas) as well as those with continence to solids and liquids.
b Parker, 200357e has two group of patients. Group 1e long term follow-up of patients fromWong et al.103 and 37 other patients.
c Only 6 patients could be contacted to assess the success.from 9 months to more than 5 years,11,52,53 again
depending on the definitions of success. The
results from larger series suggest that the success
rate is nearly 50% overall.54 At least 30e40% of
these devices are removed for a variety of rea-
sons.52,54e61 However, once functional, the artifi-
cial bowel sphincter seems to improve the
continence in a majority of patients, who retain it.
The main problems associated with the artificial
sphincter seem to be the high explantation rates
due to infection, erosion, pain and obstructive
defaecation. MRSA associated sepsis has been
a particular problem in the series reported from
the UK causing many failures and leading to
removal of 33% of these devices.55 Romano and
associates62 believe that the infection rate in the
ABS can be reduced by locating the device far from
the skin and loose around the bowel, absolute
sterility, and by suturing a finger glove to the
neoanus that allows insertion of a finger in the
bowel without an accidental passage of faeces.
Obstructive defaecation has also been a problem
with artificial bowel sphincter, occurring in 25e
30% of patients.53,54,63e66 Some of these also lead
to failure with subsequent removal of the device.
Sacral nerve stimulation
The electrical stimulation of peripheral nerves has
been used for treating bladder dysfunction and canbe used for incontinence as well as retention of
urine by stimulating the appropriate nerves.67 This
is called neuromodulation and this has been used
extensively for the treatment of bladder dysfunc-
tion.68,69 This has now been extended and is being
used for bowel incontinence.
Although all the actions involved in defecation,
namely, propagation of contraction from colon to
rectum, rectal relaxationand internal anal sphincter
relaxation were reproducible in dogs by sacral nerve
stimulation, intradural sacral nerve stimulation
stimulated the pudendal nerve and caused contrac-
tion of the external anal sphincter and other pelvic
muscles.70 Thus, by stimulating the sacral para-
sympathetic nerves at the periphery of the sacral
plexus, it is possible to improve the continence.
The sacral nerve stimulation involves a period of
evaluation using percutaneous nerve stimulation
and only when this results in successful continence
in an individual patient is the definitive stimulator
implanted. The technique of percutaneous nerve
evaluation and definitive stimulator implant has
been described in detail by Ganio et al.71 in their
study on sacral nerve stimulation for the treat-
ment of bowel incontinence.
Other modifications of this technique include
bilateral sacral nerve stimulation72 and percuta-
neous implantation of the device.73,74 Both are
considered safe and effective.
Reports are available on about 80 patients who
underwent sacral nerve stimulation at different
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(a) Results
Study
(Author, Year, Ref)
Number of patients Follow-up (months) Continent or major improvement
in continence (%)a
Vaizey et al., 1999106 12 Nerve evaluation only 7 (58%)
Malouf et al., 2000107 5 16 4 (80%)
Rosen et al., 2001108 16 15 12 (75%)
Ganio et al., 200171 5 19 5 (100%)
Ganio et al., 200171 23 Nerve evaluation only 14 (61%)
Leroi et al., 200176 6 6 3 (50%)
Leroi et al., 200176 11 Temporary 8 (78%)
Kenefick et al., 200277 15 24 11 (73%)
Matzel et al., 200475 34 24 12 (35%) fully continent
83% showed decrease in total number
of incontinent episodes per week
(b) Complication
Study
(Author, Year, Ref)
Number
of patients
Obstructive
defaecation (%)
Infection
(%)
Explantation
(%)
Electrode displacement (%),
Pain (%)
Vaizey et al., 1999106 12 Electrode
displacement 4 (33%)
Malouf et al., 2000107 5 Electrode
displacement 1 (20%)
Rosen et al., 2001108 16 4 (25%) Electrode
displacement 2 (13%)
Ganio et al., 200171 23 Electrode
displacement 4 (17%)
Leroi et al., 200176 6 Electrode
displacement 3 (50%)
Kenefick et al., 200277 15 1 (7%) Lead
displacement 2 (13%),
Pain 3 (20%)
Matzel et al., 200475 34 Deterioration of
bowel habits 3 (9%)
9 (26%) 1 (3%) Repositioning 3 (9%),
Pain 9 (26%)
a Variable definitions of success were used by different authors. Most considered successful (or good) result to encompass full
continence (solids, liquid and gas) as well as those with continence to solids and liquids.centres (Table4ae results,becomplications).All the
studies reported small numbers of patients with
overall success rates varying between 35% and 100%
with a follow-up ranging from 6 months to 2
years.71,75e77 The main risks in the sacral nerve
stimulation seem to be infection (which may neces-
sitate explantation of the device) and electrode
displacement. Pain is another important complication
which may necessitate explantation of the device.
Only a small percentage of patients who un-
derwent sacral nerve evaluation went on to have
permanent implants in some centres.71,76,78 Also,
all the studies involve a small number of patients
and the follow-up period is short. But as the device
is used more, more studies with a larger number
are likely to be done and these will show the long
term success of the procedure. It remains to be
seen whether the chronic stimulation of nerves
leads to diminished response.Other procedures
In the continuing search for an ideal solution for
faecal incontinence, various other procedures are
being attempted. Some of them like the use of
stimulated smooth muscle as neosphincters are
animal studies,79 while others like multiple silicon
injections,80,81 expandable microballoons82 and ra-
diofrequency delivery deep to the anal mucosa e
SECCA83e85 have been carried out in a very small
number of patients and are still being evaluated.
Discussion
Medical therapy, including measures such as anti-
diarrhoeals, bulk laxatives, and biofeedback, may
substantially benefit some patients with faecal
incontinence and should be tried first. Surgical
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patients, mainly those with anal sphincter defect,
secondary to obstetric trauma or fistula surgery.
Overlapping anal sphincter repair is the most
commonly used method especially in old sphincter
defects, although apposition repair can be used in
fresh injuries. Sometimes, repairs are done by
plication, usually in conjunction with anterior
levatorplasty in anterior sphincter defects.
An overlapping sphincteroplasty has been re-
ported to improve continence in more than 50e
80% of incontinent patients86e90 and is considered
to be the procedure of choice91 in the presence of
localized sphincter defects. The long term results
of sphincter repair have shown some deterioration
in continence with the passage of time.92 Patients
with failed sphincter repair usually benefit from
another attempt, if there is evidence of disruption
or inadequate repair.86,93 Eventually, a proportion
of these patients will fail and may end up having
a stoma, unless other continent alternatives are on
offer.
It is thought that sphincter repairs may have
a lower success rate in patients with pudendal
neuropathy,94 although this is not universally
agreed upon. Moreover, sphincteroplasty, for ob-
vious reasons, is not suitable for patients with
absent anal sphincter (congenital anorectal mal-
formations), extensive sphincter destruction, neu-
romuscular disorders and in patients who have had
abdominoperineal resection performed on them
for carcinoma of the rectum. All such patients may
end up with stoma in the absence of continent
alternatives.
While many patients with stomas have good
quality of life, it is obvious that in other patients
stomas may have a profoundly negative impact on
the quality of life of patients.4 In one study, it was
found that more than a fifth of the patients with
stoma had felt that their stomas has adversely
affected their travel, while 10% had to change the
nature of their work.5 Self image and sex life may
be affected as well. Some patients report disap-
pointment and frustration not only in themselves
but also among their spouses. A substantial num-
ber of the patients who underwent permanent
stoma stated that their spouses reacted with
caution or in a negative manner.95,96 About 40%
of patients who had stoma had their sex lives
affected.5
The neosphincters are alternatives for perma-
nent stoma and may be considered for patients
requiring permanent stoma for incontinence. How-
ever, artificial bowel sphincter may be unsuitable
in patients with a scarred perineum due to pre-
vious surgery or irradiation97 although, they arepreferred over dynamic graciloplasty in patients
with neuromuscular disorders involving the gracilis
or its nerve supply and are more convenient than
dynamic graciloplasty in institutions that treat
a small number of patients.98 Compared to elec-
trostimulated muscle transfers, artificial bowel
sphincters are cheaper, easier for the surgeon to
implant, restore continence immediately on acti-
vation and can be assessed with radiographic-
imaging techniques. On the other hand, they suffer
from high incidence of infections, erosion and
mechanical failure and the results of dynamic
graciloplasty may be superior to artificial bowel
sphincters in experienced centres.
Electrostimulated neosphincter is contraindi-
cated in patients with cardiac pacemakers.18 Any
form of anal neosphincters should not be contem-
plated in patients with persistent perineal sepsis,
Crohn’s disease58 or patients at high risk of cancer
recurrence, whether pelvic or systemic following
rectal excision.
Some of the difficulty in analysing these results
stems from the fact that some patients have been
included in more than one report and hence the
results had to be interpreted with caution in order
to avoid duplication. Some of the individual studies
have also been included in multicentric trial
results e making the interpretation difficult. Fur-
thermore, the definitions of success and full
continence differ between papers. This makes it
difficult to accurately compare results of different
series.
Furthermore, all these studies are case series
reports and there are no available randomized
clinical trials in this field. We acknowledge that it
would be difficult to randomize people to surgical
treatment and no treatment/placebo because of
ethical issues. However, randomized trials com-
paring the different treatments are quite feasible,
although issues about blinding the patient would
still exist.
Nevertheless, some meaningful figures regard-
ing success and complications are possible (Tables
1e4), which can be considered by the surgeon and
the patient while contemplating these procedures.
Conclusions
Current continent surgical alternatives to perma-
nent colostomy have high complication rates and
have moderate success rates only. The ideal pro-
cedure for restoring continence in this group of
patients is elusive. A major proportion of patients
will need reoperations and hence a high motiva-
tion is necessary for patients who undergo these
202 K.S. Gurusamy et al.procedures. A uniform standard for measurement
of success is also necessary so that these proce-
dures can be compared with each other. It would
also be interesting to find out the comparison of
the quality of life measures between these differ-
ent procedures and permanent colostomy. Long
term results are still awaited for many of these
procedures. It would be interesting to see if these
procedures stand the test of time.
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